Advertisement

Nivolumab Combination Regimens in Previously Untreated Patients With Advanced Esophageal Squamous Cell Carcinoma
Posted: 02/09/2022 | By: Matthew Stenger

Question 1 of 5

Compared with chemotherapy, nivolumab plus chemotherapy significantly improved:

Choose 1

A
Overall survival in the PD-L1–positive population
B
Overall survival in the total population
C
Progression-free survival in the PD-L1–positive population
D
All of the above

CategoriesView All Quizzes

Tumor Type


Additional Topics



Conference Coverage